| 837442 |
Brazil |
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
|
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
|
2022-05-30 |
|
|
| PT name |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
| Scheme name in national language |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
|
| 947164 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation
[EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação]
Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation
[EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação]
|
2022-07-26 |
|
|
| PT name |
(Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation) |
| Scheme name in national language |
(EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação) |
| Tested property |
(Coronavirus (SARS-CoV2): antigen research by automation) |
|
| 705717 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
| 1009007 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva]
Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva) |
| Scheme name in national language |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva) |
| Tested property |
(Molecular Biology - Coronavirus (SARS-CoV2): saliva) |
|
| 705758 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)) |
|
| 1050992 |
France |
CTCB
CTCB
|
RNA SARS-CoV2 (virology)
[ARN SARS-CoV2 (virologie)]
RNA SARS-CoV2 (virology)
[ARN SARS-CoV2 (virologie)]
|
2023-05-24 |
|
|
| PT name |
(RNA SARS-CoV2 (virology)) |
| Scheme name in national language |
(ARN SARS-CoV2 (virologie)) |
| Test item |
(Detection of SARS-CoV2 RNA) |
| Tested property |
(ARN SARS-CoV2 - cell culture supernatant) |
|
| 880833 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular panel of Respiratory Infections and Pneumonia
[EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias]
Clinical PT - Molecular panel of Respiratory Infections and Pneumonia
[EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias]
|
2023-05-29 |
|
|
| Tested property |
(Coronavírus (SARS-CoV-2)) |
|
| 1051761 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Sequencing: Coronavirus (SARS-CoV2)
[EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)]
Clinical PT - Sequencing: Coronavirus (SARS-CoV2)
[EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)]
|
2023-05-29 |
|
|
| PT name |
(Clinical PT - Sequencing: Coronavirus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)) |
|
| 699949 |
United Kingdom |
UK NEQAS for Immunology, Immunochemistry & Allergy
UK NEQAS for Immunology, Immunochemistry & Allergy
|
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
|
2023-05-30 |
|
|
| PT name |
(UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies) |
| Tested property |
(SARS-CoV-2 / COVID-19 Antibodies) |
|
| 935461 |
United Kingdom |
UK NEQAS for Microbiology
UK NEQAS for Microbiology
|
SARS-CoV-2 Point of Care
[SARS-CoV-2 Point of Care]
SARS-CoV-2 Point of Care
[SARS-CoV-2 Point of Care]
|
2023-07-14 |
|
|
| PT name |
(SARS-CoV-2 Point of Care) |
| Scheme name in national language |
(SARS-CoV-2 Point of Care) |
| Tested property |
(To determine the presence / absence of SARS-CoV-2 antigen/ nucleic acid by point of care devices such as lateral flow, LAMP and antigen test) |
|
| 143893 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Cosmetics and Toiletries Scheme (COSMETICS)
Cosmetics and Toiletries Scheme (COSMETICS)
|
2023-09-11 |
|
|
| Tested property |
(Relevant to SARS-CoV-2 pandemic) |
|
| 1083473 |
Brazil |
METROCERT
METROCERT
|
P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone
[P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular]
P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone
[P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular]
|
2023-10-19 |
|
|
| PT name |
(P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone) |
| Scheme name in national language |
(P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular) |
| Tested property |
(Specific Absorption Rate (SAR)) |
|
| 1129430 |
Spain |
ielab
ielab
|
SARS-CoV-2
[SARS-CoV-2]
SARS-CoV-2
[SARS-CoV-2]
|
2023-11-29 |
|
|
| PT name |
(SARS-CoV-2) |
| Scheme name in national language |
(SARS-CoV-2) |
| Tested property |
(SARS-CoV-2) |
|
| 883284 |
Thailand |
Department of Medical Sciences PT provider (DMSc PT provider)
Department of Medical Sciences PT provider (DMSc PT provider)
|
SARS-CoV-2 detection by Real-time RT-PCR
[SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)]
SARS-CoV-2 detection by Real-time RT-PCR
[SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)]
|
2024-01-09 |
|
|
| PT name |
(SARS-CoV-2 detection by Real-time RT-PCR) |
| Scheme name in national language |
(SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)) |
|
| 1138638 |
Canada |
CMPT - Canadian Microbiology Proficiency Testing
CMPT - Canadian Microbiology Proficiency Testing
|
COVID-19
COVID-19
|
2024-01-23 |
|
|
| PT name |
(COVID-19) |
| Tested property |
(SARS CoV-2) |
|
| 706310 |
Portugal |
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
|
SARS-CoV-2, molecular detection
[SARS-CoV-2, molecular detection]
SARS-CoV-2, molecular detection
[SARS-CoV-2, molecular detection]
|
2024-03-13 |
|
|
| PT name |
(SARS-CoV-2, molecular detection) |
| Scheme name in national language |
(SARS-CoV-2, molecular detection) |
| Tested property |
(SARS-CoV-2 virus) |
|
| 1163345 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – SARS-CoV-2 sequence analysis (417)
[Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)]
Virus Genome Detection – SARS-CoV-2 sequence analysis (417)
[Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)]
|
2024-04-16 |
|
|
| PT name |
(Virus Genome Detection – SARS-CoV-2 sequence analysis (417)) |
| Remarks |
(Please note:
Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2) |
| Scheme name in national language |
(Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)) |
| Tested property |
(Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing) |
|
| 1163338 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – SARS-CoV-2 (409)
[Virusgenom-Nachweis - SARS-CoV-2 (409)]
Virus Genome Detection – SARS-CoV-2 (409)
[Virusgenom-Nachweis - SARS-CoV-2 (409)]
|
2024-04-16 |
|
|
| PT name |
(Virus Genome Detection – SARS-CoV-2 (409)) |
| Scheme name in national language |
(Virusgenom-Nachweis - SARS-CoV-2 (409)) |
| Tested property |
(The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2) |
|
| 1163321 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)]
Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)]
|
2024-04-16 |
|
|
| Tested property |
(influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated)) |
|
| 1163304 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)]
Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)]
|
2024-04-16 |
|
|
| Tested property |
(incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively) |
|
